SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation

NCT04631705 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

45

Enrollment

OTHER

Sponsor class

Stopped Change in viral variant epidemiology

Conditions

SARS-CoV-2 Infection

Interventions

BIOLOGICAL: DZIF-10c
BIOLOGICAL: DZIF-10c
DRUG: Placebo
DRUG: Placebo

Sponsor

University of Cologne

Collaborators

[object Object]
[object Object]